You have 9 free searches left this month | for more free features.

intracellular molecular pathway

Showing 1 - 25 of 8,894

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

TNBC - Triple-Negative Breast Cancer Trial (A1:SG with SHR3680, A2:SG, B1:SG with SHR1210)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • A1:SG with SHR3680
  • +7 more
  • (no location specified)
Jun 23, 2023

Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

Active, not recruiting
  • HER2-positive Breast Cancer
  • RNA sequencing
  • +3 more
  • Walnut, California
  • +3 more
Sep 13, 2021

Heart Failure, Ischemic Cardiomyopathy Trial in Roma (Blood sample)

Active, not recruiting
  • Heart Failure
  • Ischemic Cardiomyopathy
  • Blood sample
  • Roma, Italy
    Fondazione Policlinico Gemelli
Feb 27, 2023

Molecular Diagnosis of Systemic Autoinflammatory Diseases

Not yet recruiting
  • Inflammatory Disease
  • +4 more
    • Paris, France
      Trousseau Hospital
    May 23, 2022

    Recurrent Endometrial Carcinoma, Recurrent Ovarian Carcinoma Trial (Biopsy, Biospecimen Collection, Bone Marrow Aspiration and

    Not yet recruiting
    • Recurrent Endometrial Carcinoma
    • Recurrent Ovarian Carcinoma
    • Biopsy
    • +5 more
    • (no location specified)
    Sep 29, 2022

    Colo-rectal Cancer, Molecular Pathway Deregulation Trial in Seongnam-si

    Active, not recruiting
    • Colo-rectal Cancer
    • Molecular Pathway Deregulation
      • Seongnam-si, Gyeonggi-do, Korea, Republic of
        Seoul National University Bundang Hospital
      May 3, 2022

      Solid Tumors Trial in Toronto (Afatinib)

      Active, not recruiting
      • Solid Tumors
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      May 12, 2022

      Colorectal Cancer, KRAS Wildtype, NRAS Wildtype Trial in Toronto (Trametinib, Panitumumab)

      Completed
      • Colorectal Cancer
      • +3 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      May 12, 2022

      Breast Cancer Trial in Shanghai (A, B, CL1)

      Recruiting
      • Breast Cancer
      • A
      • +8 more
      • Shanghai, Please Select, China
      • +1 more
      Nov 27, 2021

      Pancreatic Cancer, Adenocarcinoma Trial in Canada (GSK2256098, Trametinib)

      Active, not recruiting
      • Pancreatic Cancer
      • Adenocarcinoma
      • Hamilton, Ontario, Canada
      • +3 more
      May 12, 2022

      Cancer Target Therapy Efficacy

      Active, not recruiting
      • Cancer
      • RNA sequencing
      • +5 more
      • Walnut, California
      • +6 more
      Sep 13, 2021

      TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

      Not yet recruiting
      • TNBC - Triple-Negative Breast Cancer
      • Alkaline Glucosodiene Molecules
      • (no location specified)
      Jul 14, 2023

      RASopathy, Costello Syndrome, Cardio-Facio-Cutaneous Syndrome Trial in Roma (Molecular characterization of solid tumor in

      Recruiting
      • RASopathy
      • +3 more
      • Molecular characterization of solid tumor in RASopathies
      • Roma, Italy
        Department of Woman and Child Health and Public Health, Fondazio
      Feb 27, 2023

      Cardiac Tissue in Postnatal Development

      Recruiting
      • Congenital Heart Disease
      • Tetralogy of Fallot
        • Atlanta, Georgia
          Emory University School of Medicine
        Jun 21, 2022

        Parkinson Disease, Gait Analysis, Therapy, Directly Observed Trial (Terazosin)

        Not yet recruiting
        • Parkinson Disease
        • +3 more
        • (no location specified)
        May 3, 2023

        Sebaceous Cell Tumor of Eyelid Trial in Roma (exome sequencing (retrospective) and exome and methylome sequencing (prospective))

        Recruiting
        • Sebaceous Cell Tumor of Eyelid
        • exome sequencing (retrospective) and exome and methylome sequencing (prospective)
        • Roma, Rome, Italy
          Gustavo Savino
        Oct 8, 2023

        Hyperferritinemia Candidate Gene

        Recruiting
        • Hyperferritinemia
        • Genetic analysis
        • Monza, MB, Italy
          Centre for Rare Disease - Disorders of Iron Metabolism, ASST-Mon
        Jan 17, 2023

        Brain Derived Neurotrophic Factor rs6265 Gene Polymorphism With

        Not yet recruiting
        • Epilepsy
        • Genotyping by Real Time PCR
        • (no location specified)
        Oct 14, 2021

        Metastatic Lung Cancer, Metastatic Gastrointestinal Cancer Trial (FoundationOne® Liquid CDx Assay, Standard of Care Diagnostic

        Not yet recruiting
        • Metastatic Lung Cancer
        • Metastatic Gastrointestinal Cancer
        • FoundationOne® Liquid CDx Assay
        • Standard of Care Diagnostic Pathway
        • (no location specified)
        May 11, 2023

        TNBC - Triple-Negative Breast Cancer Trial in Shanghai (A1: Pyrotinib with Capecitabine, A2: nab-paclitaxel, B1: everolimus with

        Recruiting
        • TNBC - Triple-Negative Breast Cancer
        • A1: Pyrotinib with Capecitabine
        • +9 more
        • Shanghai, Shanghai, China
          Cancer Hospital Affiliated to Fudan University
        May 19, 2020

        Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

        Active, not recruiting
        • Advanced Malignant Solid Neoplasm
        • +35 more
        • Birmingham, Alabama
        • +108 more
        Oct 19, 2022

        Microbiota and Metabolites Alterations in Pancreatic Head and

        Completed
        • Pancreatic Ductal Adenocarcinoma (PDAC)
        • 16S rRNA amplicon sequencing and untargeted metabolomics
        • Jinan, Shandong, China
          Qilu Hospital of Shandong University
        Nov 27, 2023

        Respiratory Failure Trial in Boston (Normoxia with Normocarbia, Normoxia with Hypercarbia, Hyperoxia with Normocarbia)

        Terminated
        • Respiratory Failure
        • Normoxia with Normocarbia
        • +3 more
        • Boston, Massachusetts
          Beth Israel Deaconess Medical Center
        Mar 7, 2022

        Obstructive Sleep Apnea, Obesity Trial in Prague (Dietary and physical intervention)

        Recruiting
        • Obstructive Sleep Apnea
        • Obesity
        • Dietary and physical intervention
        • Prague, Czechia
          University Hospital Královské Vinohrady
        Feb 15, 2022

        Depressive Disorder Trial in Tanta (Fluoxetine 20 mg, Dapagliflozin 10mg Tab, Atorvastatin 80mg)

        Not yet recruiting
        • Depressive Disorder
        • Fluoxetine 20 mg
        • +2 more
        • Tanta, Shebeen El-Kom, Egypt
          Faculty of Medicine, Menoufia University
        Mar 19, 2023